A 35-year-old woman is evaluated in the clinic for a routine follow-up 3 months after unde… — USMLE Step 2 CK

A $35$ -year-old woman is evaluated in the clinic for a routine follow-up $3$ months after undergoing a total thyroidectomy and central compartment lymph node dissection for classical papillary thyroid carcinoma. Her postoperative course was complicated by permanent hypoparathyroidism due to inadvertent parathyroid gland resection, requiring continuous calcium and active vitamin D supplementation.

The patient currently feels well and reports no muscle cramping, perioral numbness, or tingling. Her medications include levothyroxine $125$ mcg daily, calcium carbonate $1000$ mg three times daily, and calcitriol $0.5$ mcg twice daily.

Vital signs are within normal limits. Physical examination reveals a well-healed Kocher incision and negative Chvostek and Trousseau signs.

Laboratory studies show the following:
Serum calcium: $9.3$ mg/dL (normal $8.4$ - $10.2$ mg/dL)
Serum phosphorus: $4.2$ mg/dL (normal $2.7$ - $4.5$ mg/dL)
Serum albumin: $4.0$ g/dL
Thyroid-stimulating hormone (TSH): $0.3$ $\mu$ U/mL (normal $0.5$ - $5.0$ $\mu$ U/mL)
Intact PTH: $8$ pg/mL (normal $15$ - $65$ pg/mL)
$24$ -hour urine calcium: $450$ mg/day (normal < $250$ mg/day)

Renal ultrasound demonstrates no nephrolithiasis.

What is the most appropriate next step in management to prevent long-term complications in this patient?

Decrease the dose of calcium carbonate and calcitriolAnswer
B
Add hydrochlorothiazide to the current regimen
C
Add furosemide to the current regimen
D
Increase the dose of levothyroxine
E
Continue the current regimen and observe

Answer

Decrease the dose of calcium carbonate and calcitriol

The correct next step is to decrease the dose of calcium carbonate and calcitriol. This patient has iatrogenic permanent hypoparathyroidism and hypercalciuria (

24

-hour urine calcium >

250

mg/day). Parathyroid hormone (PTH) normally stimulates calcium reabsorption in the distal convoluted tubule of the kidney. In patients with hypoparathyroidism, this mechanism is lost, resulting in excessive renal calcium excretion for any given serum calcium level. Because of this obligatory calcium leak, normalizing the serum calcium (as seen in this patient with a level of

9.3

mg/dL) results in severe hypercalciuria, placing the patient at high risk for nephrolithiasis, nephrocalcinosis, and chronic kidney disease. Therefore, the therapeutic goal in hypoparathyroidism is NOT to achieve a normal serum calcium level, but rather to maintain an asymptomatic state with a low-normal serum calcium level (typically

8.0

8.5

mg/dL). This minimizes the filtered calcium load and reduces urinary calcium excretion. The most appropriate initial step is to decrease the calcium and calcitriol dosages to bring her serum calcium down to the target range.

Step-by-Step Solution

Analyze the patient's postoperative complication and current laboratory values.

The patient has iatrogenic permanent hypoparathyroidism following a thyroidectomy, presenting with a currently normal serum calcium (

9.3

mg/dL) but severe hypercalciuria (

450

mg/day).

Identifying the discrepancy between the normal serum calcium and the dangerously high urine calcium is essential for recognizing the physiological deficit.

Recall the physiological effect of PTH on renal calcium handling.

PTH is required for efficient calcium reabsorption in the distal convoluted tubule of the kidney.

Without PTH, the kidneys cannot retain calcium efficiently, meaning any calcium filtered by the glomerulus will rapidly spill into the urine even at normal serum concentrations.

Determine the therapeutic goal for chronic hypoparathyroidism management.

The goal is to maintain an asymptomatic state with a low-normal serum calcium level (typically

8.0

8.5

mg/dL).

Maintaining a low-normal serum calcium minimizes the filtered load of calcium, thereby protecting the kidneys from hypercalciuria, nephrolithiasis, and nephrocalcinosis.

Select the most appropriate intervention based on the physiological goals.

Because the current serum calcium (

9.3

mg/dL) is too high for a patient without PTH, the required first step is to decrease the exogenous calcium and calcitriol.

Lowering the serum calcium will directly reduce the filtered calcium load. Adjunctive therapies like thiazide diuretics are only indicated if hypercalciuria persists despite achieving the low-normal serum calcium target.

Key Concept

The therapeutic goal in chronic hypoparathyroidism is to maintain a low-normal serum calcium level (

8.0

8.5

mg/dL) to prevent hypercalciuria and subsequent nephrocalcinosis, as the absence of PTH prevents normal renal calcium reabsorption.

Estimated Time:1m 30s

Question

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Topics

More questions from this topic